期刊文献+

神经节苷脂治疗重症手足口病患儿临床疗效及NSE和S-100β蛋白变化 被引量:8

Clinical efficacy of ganglioside on treatment of severe hand-foot-mouth disease and changes in neuron-specific enolase and S-100β protein
下载PDF
导出
摘要 目的探讨神经节苷脂对重症手足口病(HFMD)患儿疗效,以及血清神经元特异性烯醇化酶(NSE)和血浆S-100β蛋白的影响。方法某院2011年4月—2014年6月收治的140例重症HFMD患儿随机分为常规治疗组和试验组,选择同期门诊体检健康儿童30例作为正常对照组。常规治疗组予以抗病毒、降颅压等治疗;试验组在常规治疗组基础上加用神经节苷脂,比较3组儿童NSE和S-100β蛋白水平,以及常规治疗组和试验组临床疗效。结果试验组总有效率为91.43%(64/70),高于常规治疗组78.57%(55/70)(χ2=4.54,P<0.05)。重症HFMD患儿NSE及S-100β蛋白分别为(17.63±4.21)μg/L、(492.05±119.33)ng/L,均高于对照组[分别为(8.79±2.12)μg/L、(296.35±91.02)ng/L](均P<0.01)。治疗前,常规治疗组和试验组患儿血清NSE、S-100β蛋白水平比较,差异均无统计学意义(均P>0.05);治疗10 d后,两组患儿血清NSE、S-100β蛋白水平均低于治疗前(均P<0.01),且试验组NSE、S-100β蛋白下降水平分别为(10.18±2.36)μg/L、(247.55±64.64)ng/L,均高于常规治疗组[分别为(5.87±3.03)μg/L、(113.97±43.44)ng/L](均P<0.01)。结论神经节苷脂对重症HFMD患儿有明显的疗效,可有效降低脑组织损伤标志物NSE及S-100β蛋白。 Objective To evaluate the efficacy of ganglioside on treatment of severe hand-foot-mouth disease (HFMD)in children,and effect on serum neuron-specific enolase (NSE)as well as plasma S-100βprotein levels.Methods One hun-dred and forty cases of severe HFMD patients in a hospital from April 2011 to June 2014 were randomly divided into routine therapy group and trial group,and 30 healthy children who received physical examination in outpatient de-partment during the same period were selected as control.Children in routine therapy group were given antiviral and intracranial decompression therapy;trial group were administered ganglioside in addition to routine therapy ,levels of NSE and S-100 βprotein levels of 3 groups,as well as clinical efficacy between routine therapy group and trial group were compared.Results Total efficacy rate of trial group was significantly higher than routine therapy group (91 .43%[64/70]vs 78.57%[55/70],χ^2 =4.54,P〈0.05).The levels of NSE and S-100βprotein in children with severe HFMD were significantly higher than control group ([17.63±4.21)μg/L vs [8.79±2.12]μg/L;[492.05±119.33]ng/L vs [296.35±91 .02]ng/L,both P〈0.01).NSE and S-100 βprotein levels of routine therapy group and trial group before treatment were not significantly different(both P〉0.05);after 10-day treatment,NSE and
出处 《中国感染控制杂志》 CAS 北大核心 2015年第3期184-187,共4页 Chinese Journal of Infection Control
关键词 神经节苷脂 手足口病 肠道病毒感染 儿童 ganglioside hand-foot-mouth disease enterovirus infection child
  • 相关文献

参考文献11

二级参考文献60

  • 1胡传奇,马飞燕.手足口病患儿心肌酶测定及临床意义[J].实用临床医学(江西),2005,6(10):31-32. 被引量:11
  • 2李树军.病毒性脑炎患儿脑脊液和血清中S-100B蛋白的变化[J].中国小儿急救医学,2006,13(4):345-346. 被引量:7
  • 3邵晓丽,周忠蜀,洪闻,沈明,杨凌,王云峰.氢质子磁共振波谱在热性惊厥中的临床应用[J].实用儿科临床杂志,2007,22(5):373-374. 被引量:5
  • 4Rabenau HF,Richter M, Doerr HW. Hand, foot and mouth disease:seroprevalence of Coxsackie A16 and Enterovirus 71 in Germany[J]. Med Microbiol Immunol, 2010, 199(1) :45.
  • 5Hsueh C ,Jung SM, Shih SR, et al. Acute encephalomyelitis during an outbreak of enterovirus type 71 infection in Tai wan : report of an autopsy case with pathologic, immunoflu- orescence, and molecular studies [ J l. Mod Pathol, 2000, 13(11) :1200.
  • 6Ooi MH, Wong SC, Mohan A, et al. Identification and validation of clinical predictors tot the risk of neurological involvement in children with hand, toot, and mouth disease in Sarawak[ J]. BMC Infect Dis ,2009,9:3.
  • 7Tseng F C, Huang H C,ChiC Y. Epidemiological survey of en terovirus infections occurring in Taiwan between 2000 and 2005 : analysis of sentinel physician surveillance data[J]. J Med Viroh 2007,79 : 1850 - 1860.
  • 8ChangLY, KingCC, HsuK H, etal. Risk factors of en-terovirus 71 infection and associated hand, foot, and mouth disease/herpangina in children during an epidemic in Taiwan [J]. Pediatrics,2002,109(6) : e88.
  • 9Ooi M H, Wong S C, Mohan A, etal. Identification and vali dation of clinical predictors for the risk of neurological involve ment in children with hand, foot, and mouth disease in Sara wak[J]. BMC Infect Dis, 2009,9~ 3.
  • 10Chang L Y, Huang L M, Gau S S, et al. Neurodevelopment and cognition in children after enterovirus 71 infection [J]. N Engl J Med, 2007,356(12) : 1226-1234.

共引文献108

同被引文献86

引证文献8

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部